Lim Dong Jun, Kwon Hyuk Sang, Cho Jae Hyoung, Kim Sang Hee, Choi Yoon Hee, Yoon Kun Ho, Cha Bong Yun, Lee Kwang Woo, Son Ho Young, Kang Sung Koo
Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.
Endocr J. 2007 Aug;54(4):537-41. doi: 10.1507/endocrj.k06-083. Epub 2007 Jun 13.
Acromegaly is caused by excessive secretion of growth hormone (GH), and a resultant persistent elevation of insulin-like growth factor-1 (IGF-1) levels. Diabetes mellitus is accompanied in some acromegalic patients with insulin resistance. We encountered a type-2 diabetic patient who had a poorly controlled glycemic state and was diagnosed as acromegaly with normal IGF-1 levels. The patient showed definite acromegalic features. However, in the first screening test, GH levels were high and IGF-1 levels were inappropriately normal so the results were not close to the diagnosis of acromegaly. After moderate glycemic control, an oral glucose suppression test was performed, showing no suppressed GH response. TRH test revealed paradoxical increases in growth hormone levels and a brain MRI discovered a pituitary adenoma. After several-months insulin treatment, IGF-1 levels were increased to the abnormal state and GH levels were decreased without treatment for acromegaly. Here we report the rare case of acromegaly that presents inappropriately normal IGF-1 levels at the time of diagnosis in uncontrolled type 2 diabetic patient and shows increased IGF-1 levels after glycemic control with insulin therapy. When evaluating acromegaly in type 2 diabetes under poorly controlled glycemia, cautious IGF-1 analysis is needed after sufficient glycemic control.
肢端肥大症由生长激素(GH)分泌过多以及由此导致的胰岛素样生长因子-1(IGF-1)水平持续升高引起。一些肢端肥大症患者伴有胰岛素抵抗,从而并发糖尿病。我们遇到一名2型糖尿病患者,其血糖控制不佳,被诊断为IGF-1水平正常的肢端肥大症。该患者表现出明确的肢端肥大症特征。然而,在首次筛查试验中,GH水平升高而IGF-1水平却异常正常,因此结果与肢端肥大症的诊断不符。在适度控制血糖后,进行了口服葡萄糖抑制试验,结果显示GH反应未被抑制。促甲状腺激素释放激素(TRH)试验显示生长激素水平反常升高,脑部磁共振成像(MRI)发现垂体腺瘤。经过数月的胰岛素治疗后,IGF-1水平升高至异常状态,且未进行肢端肥大症治疗的情况下GH水平下降。在此,我们报告这例罕见的肢端肥大症病例,该病例在未控制的2型糖尿病患者诊断时IGF-1水平异常正常,而在胰岛素治疗控制血糖后IGF-1水平升高。在评估血糖控制不佳的2型糖尿病患者的肢端肥大症时,在充分控制血糖后需要谨慎进行IGF-1分析。